Nishal Madujith Egodawaththa

Mr. Nishal Madujith Egodawaththa

BCES, Florida Institute of Technology, Melbourne, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2025 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SMShaymaa Mohamed
Shaymaa Mohamed
AEAsmaa M. Elsherbini
Asmaa M. Elsherbini
Heba R. AlrefaeyHeba R. Alrefaey
Heba R. Alrefaey
KEkareem Abd El-Rahman
kareem Abd El-Rahman
AMAlshaimaa Moustafa
Alshaimaa Moustafa
SSSally A. Sabra
Sally A. Sabra
Gum Arabic (GA), or acacia gum, refers to the dried exudate produced by certain Acacia trees. GA is composed mainly of a mixture of polysaccharides and glycoproteins, with proportions that can slightly differ from one species to another. It is commonly utilized in the food and pharmaceutical industries as a stabilizer or an emulsifier owing to its biocompatibility, hydrophilicity, and antibacterial properties. In addition, GA can be manipulated as it possesses many functional groups that can be used in grafting, cross-linking, or chemical modifications to add a new feature to the developed material. In this review, we highlight recent GA-based formulations, including nanoparticles, hydrogels, nanofibers, membranes, or scaffolds, and their possible applications in tissue regeneration, cancer therapy, wound healing, biosensing, bioimaging, food packaging, and antimicrobial and antifouling membranes.

Verified
Journal Article
Open access
PDF file
NENishal Madujith Egodawaththa
Nishal Madujith Egodawaththa
AKAmy L. Knight
Amy L. Knight
JMJingxuan Ma
Jingxuan Ma
AKAndrew Knight
Andrew Knight
EGEric Guisbert
Eric Guisbert
NNNasri Nesnas
Nasri Nesnas
Silver is a well-established antimicrobial agent. Conjugation of organic ligands with silver nanoparticles has been shown to create antimicrobial nanoparticles with improved pharmacodynamic properties and reduced toxicity. Twelve novel organic ligand functionalized silver nanoparticles (AgNPs) were prepared via a light-controlled reaction with derivatives of benzothiazole, benzoxazine, quinazolinone, 2-butyne-1,4-diol, 3-butyne-1-ol, and heptane-1,7-dioic. UV-vis, Fourier-transform infrared (FTIR) spectroscopy, and energy-dispersive X-ray (EDAX) analysis were used to confirm the successful formation of ligand-functionalized nanoparticles. Dynamic light scattering (DLS) revealed mean nanoparticle diameters between 25 and 278 nm. Spherical and nanotube-like morphologies were observed using transmission electron microscopy (TEM) and scanning electron microscopy (SEM). Seven of the twelve nanoparticles exhibited strong antimicrobial activity and five of the twelve demonstrated significant antibacterial capabilities against E. coli in a zone-of-inhibition assay. The synthesis of functionalized silver nanoparticles such as the twelve presented is critical for the further development of silver-nanoconjugated antibacterial agents.

1 June 2026 in Biomedical Materials
Verified
Journal Article
Open access
Heba R. AlrefaeyHeba R. Alrefaey
Heba R. Alrefaey
FMFayed A K Megahed
Fayed A K Megahed
KAKareem Abdelrahman
Kareem Abdelrahman
AEAsmaa M Elsherbini
Asmaa M Elsherbini
AWAl-Hassan Soliman Wadan
Al-Hassan Soliman Wadan
Ahmed El-GendyAhmed El-Gendy
Ahmed El-Gendy
Cancer is among the fatal diseases that affect individuals worldwide. According to World Health Organization statistics, if the current trends continue, the world will see a significant increase in cancer cases over the next two decades, leading to a staggering number of deaths by 2040. Therefore, finding innovative strategies for cancer treatment has become a critical priority. Recently, magnetic nanoparticles (MNPs) have been widely applied in cancer diagnosis via magnetic resonance imaging, in hyperthermia, and in drug delivery to specific organs due to their unique physicochemical properties. However, the most significant challenge of using MNPs is ensuring compliance with in vivo nano-safety regulations. MNP characteristics necessary for biomedical applications, followed by a description of their physical, chemical, and magnetic properties. The preparation of MNPs and the development of a superior method suitable for magnetic drug delivery and hyperthermia applications are surveyed. Furthermore, their physicochemical properties and their effects on biocompatibility, biodistribution, and pharmacokinetic behavior, are reported. The functionalization and surface modification of MNPs, which are intensively exploited in cancer treatment, particularly for drug delivery and hyperthermia, are demonstrated. Some studies of the incorporation of MNPs in the diagnosis, treatment, and imaging of cancer are summarized. Furthermore, the effects of combining antineoplastic drugs via drug delivery systems with hyperthermia treatment to achieve an efficient synergetic effect are extensively reviewed. Finally, this review article provides an overview of recent innovations, future challenges, prospects, and developments that advance MNP therapeutic applications, particularly in oncology.

7 March 2024 in ChemRxiv
Verified
Preprint
Open access
PDF file
NENishal Madujith Egodawaththa
Nishal Madujith Egodawaththa
OROlivia Rajhel
Olivia Rajhel
JMJingxuan Ma
Jingxuan Ma
CGCharitha Guruge
Charitha Guruge
APAlec B. Pabarue
Alec B. Pabarue
NNNasri Nesnas
Nasri Nesnas
Calcium ion (Ca2+) control is an essential tool in neuronal research. Herein, we report three thiocoumarin-based, visi-ble light-activated Ca2+ chelators with high quantum yields of 0.39, 0.52, and 0.83. The chelators demonstrated an over 10^5-fold increase in Ca2+ binding affinity upon irradiation. These chelators are efficiently triggered by biologically safer wavelengths, rendering them excellent candidates for use in neuroscientific research and medicine.

25 July 2024 in Asian Journal of Chemistry
Verified
Journal Article
Open access
PDF file
VHVisal C. Lorensu Hewage
Visal C. Lorensu Hewage
MGMedha Jaimini Gunaratna
Medha Jaimini Gunaratna
NENishal Madujith Egodawaththa
Nishal Madujith Egodawaththa
NNNasri Nesnas
Nasri Nesnas
In this study, four different 4-arylidene-2-phenyloxazol-5(4H)-ones (5a-d), were synthesized via the Erlenmeyer-Plöchl reaction and characterized by FT-IR, 1H NMR, 13C NMR and mass spectroscopic techniques. Evaluation of their in vitro anti-inflammatory activities using the heat-induced human red blood cell (HRBC) membrane stabilization assay revealed concentration dependent inhibitory effects. The IC50 values of 5a, 5b, 5c and 5d were reported as 4.65 ± 0.22 mM, 7.34 ± 0.28 mM, 5.23 ± 0.18 mM and 1.96 ± 0.09 mM, respectively. O-Acetyl salicylic acid as standard showed its IC50 value at 6.41 ± 0.18 mM. Docking studies against human cyclooxygenase (COX) 1 and 2 revealed affinities of the compounds to binding cavities of COX enzymes. Particularly, compound 5d exhibited remarkable activity in both HRBC membrane stabilization and the formation of hydrogen bonds with binding cavities. This suggests a potential correlation between the number of hydroxyl groups of oxazolone derivatives and the enhancement of anti-inflammatory activity.

16 August 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DPDimithri Himasha Pathirana
Dimithri Himasha Pathirana
Upeka Chathurangani DelpachitraUpeka Chathurangani Delpachitra
Upeka Chathurangani Delpachitra
Julian VladJulian Vlad
Julian Vlad
DDD. M. W. S. Dissanayake
D. M. W. S. Dissanayake
YAYasiru Vindula Alwis
Yasiru Vindula Alwis
MGMedha Jaimini Gunaratna
Medha Jaimini Gunaratna
Background/Objectives: Diabetes mellitus is a common endocrine disorder characterized by hyperglycemia, which is increasing steadily all over the world. Current medications are limited due to lower efficacy and side effects; therefore, the introduction of novel compounds is crucial to improve therapeutic outcomes for diabetic patients. The objective of this study was to synthesize and evaluate 2-phenyl-3H-quinazolin-4-one and its derivatives for the glucose uptake across the yeast cell membranes, alpha-amylase inhibition, and alpha-glucosidase inhibition in silico and in vitro. Methods: The synthesis of 2-phenyl-3H-quinazolin-4-one and its derivatives was carried out by oxidative cyclocondensation of 2-aminobenzamide (anthranilamide) with various benzaldehydes in the presence of aqueous iron (III) chloride. The synthesized compounds were characterized by melting point determination and spectroscopic techniques, including FTIR, NMR and HRMS. Results: In the glucose uptake by yeast assay, compound 3f had a lower 50% glucose uptake value of 24.02 ± 0.96 mM, compared with the standard drug metformin (25.99 ± 2.41 mM). The alpha-amylase inhibition bioassay showed that compound 3e exhibited very potent inhibition, with an IC50 of 0.43 ± 0.05 mM, compared with the standard drug acarbose (0.53 ± 0.21 mM). Compound 3l exhibited strong alpha-glucosidase inhibition, with an IC50 of 0.42 ± 0.10 mM, compared with the standard drug acarbose (0.29 ± 0.50 mM). Coclusions: These findings suggest the potential of synthesized 2-phenyl-3H-quinazolin-4-one derivatives, 3a–o, as promising candidates for managing diabetes mellitus. However, further studies are required to validate their efficacy and determine their mechanisms of action.